Table 2 CT imaging features of patients with MDR/RR/pre-XDR-TBTB using bedaquiline or delamanid or none.
Characteristics, N (%) | Total (n = 101) | Bedaquiline (n = 32) | Delamanid (n = 25) | Non-bedaquiline or delamanid (n = 44) | χ2 | P value |
|---|---|---|---|---|---|---|
Lung damage | 15 (14.9) | 7 (21.9) | 2 (8.0) | 6 (13.6) | 2.069a | 0.373 |
Pulmonary atelectasis | 43 (42.6) | 5 (15.6) | 13 (52.0) | 25 (56.8) | 14.066 | 0.001 |
Airway stenosis | 70 (69.3) | 22 (68.8) | 16 (64.0) | 32 (72.7) | 0.578 | 0.749 |
Roughness of bronchial wall | 65 (64.4) | 19 (59.4) | 14 (56.0) | 32 (72.7) | 2.451 | 0.294 |
Pulmonary cavities | 63 (62.4) | 19 (59.4) | 17 (68.0) | 27 (61.4) | 0.479 | 0.787 |
Lesions involve the lung fields | 1.569b | 0.456 | ||||
Unilateral lung, single lobe | 2 (2.0) | 1 (3.1) | 1 (4.0) | 0 (0) | ||
Unilateral lung, multiple lobes | 25 (24.8) | 5 (15.6) | 8 (32.0) | 12 (27.3) | ||
Bilateral lungs, single lobe | 1 (1.0) | 1 (3.1) | 0 (0) | 0 (0) | ||
Bilateral lungs, multiple lobes | 73 (72.3) | 25 (78.1) | 16 (64.0) | 32 (72.7) |
